Patent applications related to synthesis of heptakis(2,6-di-O-alkyl)-beta-cyclodextrin by CycloLab
45 years ago, Szejtli et al. reported on the synthesis of heptakis(2,6-di-O-methyl)-beta-cyclodextrin using dimethyl sulfate as alkylating agent in a
A forum for researchers, students and applicants in the field of cyclodextrin technology
45 years ago, Szejtli et al. reported on the synthesis of heptakis(2,6-di-O-methyl)-beta-cyclodextrin using dimethyl sulfate as alkylating agent in a
Pancreatic cancer is resistant not only to chemotherapy but also to immunotherapy; therefore, identifying strategic alternatives is still necessary. Recently,
The efficacy of cisplatin (CTN) is limited due to its short half-life and toxic side effects. This study aimed to
Thiolated oligomers and polymers, also known as thiomers, are valuable tools for non-parenteral drug delivery.1-3 Due to the cysteine-rich segments
Cyclodextrins are seldom used in sustained-release formulations, as they are more commonly associated with rapid drug delivery. However, cyclodextrin complexes
Carbohydrates are encountered in many applications across diverse fields, including glycobiology, pharmaceuticals, genetics, material chemistry, polymer chemistry, and the food
Fenofibric acid (FFA) exhibits notable anti-inflammatory potential. This research assesses the anti-inflammatory effects of FFA, both in its standalone form
📘 Cyclodextrins in Cancer Therapy (Published by Wiley)📗 Cyclodextrins in Environmental Remediation (Published by Springer Nature) These volumes aim to
This study aimed to magnetize β-cyclodextrin (β-CD) to serve as a nanocarrier for sitagliptin (Sita) in targeted drug delivery applications.
Smart biobased hydrogels have become increasingly significant in controlled drug delivery due to their ability to improve bioavailability and minimize